A high-serum Kyn/Trp ratio is also correlated with a poor prognosis after a PD-1 blockade in lung cancer, melanoma and renal cell carcinomas [22]. This evidence concerns the gene PDCD1 and hereditary clear cell renal cell carcinoma.